# ClinicalTrials.gov record NCT00926380

> PeptideScanner retained ClinicalTrials.gov record NCT00926380 at 2026-07-30T21:11:31.043Z. Its registry update date was 2018-06-29, and PeptideScanner's reviewed identity mapping was teriparatide.

- Evidence object: `story:clinicaltrials-gov-nct00926380-teriparatide:v1`
- Evidence domain: Clinical trials
- Date in source: 2018-06-29
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-08-09
- Story landing page: https://peptidescanner.com/stories/clinicaltrials-gov-nct00926380-teriparatide/
- JSON record: https://peptidescanner.com/evidence/v1/objects/clinicaltrials-gov-nct00926380-teriparatide-v1.json
- Content SHA-256: `d2985cb4dca73777afc7b7cdc0c8aed009ef2105d1745a64663771b8f42f86b4`

## Claims and source pins

### Headline

ClinicalTrials.gov record NCT00926380 ([`ctg-observation-nct00926380-2018-06-29-3ab5ab7e78da`](#source-ctg-observation-nct00926380-2018-06-29-3ab5ab7e78da))

### Summary

PeptideScanner retained ClinicalTrials.gov record NCT00926380 at 2026-07-30T21:11:31.043Z. Its registry update date was 2018-06-29, and PeptideScanner's reviewed identity mapping was teriparatide. ([`ctg-observation-nct00926380-2018-06-29-3ab5ab7e78da`](#source-ctg-observation-nct00926380-2018-06-29-3ab5ab7e78da))

### Paragraph 1

PeptideScanner retained ClinicalTrials.gov record NCT00926380 at 2026-07-30T21:11:31.043Z. Its registry update date was 2018-06-29, and PeptideScanner's reviewed identity mapping was teriparatide. ([`ctg-observation-nct00926380-2018-06-29-3ab5ab7e78da`](#source-ctg-observation-nct00926380-2018-06-29-3ab5ab7e78da))

### Paragraph 2

This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective. ([`ctg-observation-nct00926380-2018-06-29-3ab5ab7e78da`](#source-ctg-observation-nct00926380-2018-06-29-3ab5ab7e78da))

## Sources

<a id="source-ctg-observation-nct00926380-2018-06-29-3ab5ab7e78da"></a>
- **ClinicalTrials.gov record NCT00926380 · retained source version 2018-06-29:3ab5ab7e78da1be2a20c78af3eddbd21c68341f53db0ee4d05245a0068dcd280** — ClinicalTrials.gov; class A. [Open source](https://clinicaltrials.gov/study/NCT00926380) (`ctg-observation-nct00926380-2018-06-29-3ab5ab7e78da`)

## Correction lineage

No correction is recorded for this version.

## Reporting boundaries and unknowns

PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

## Suggested citation

PeptideScanner. "ClinicalTrials.gov record NCT00926380." Version 1, published 2026-08-09. https://peptidescanner.com/evidence/v1/objects/clinicaltrials-gov-nct00926380-teriparatide-v1.json SHA-256: d2985cb4dca73777afc7b7cdc0c8aed009ef2105d1745a64663771b8f42f86b4.